Equity · Healthcare
VRTX
NASDAQVertex Pharmaceuticals (VRTX)
The line runs 470.61 USD on 3 August through 559.05 USD on 30 October, on a scale from 450 to 600. Days the market did not trade hold the previous close, flat.
- Market cap
- 141.7B USD
- P/E (TTM)
- 32.6
- Revenue, year to Dec 2025
- 12.0B USD
- EPS, diluted, year to Dec 2025
- 15.32 USD
- 52-week range
- 406 USD – 559.05 USD
- Avg volume
- 71.0K
- Mentions, 30 days
- 15
- Net sentiment
- +0.08
as of Oct 30, 2026
Have Vertex Pharmaceuticals (VRTX) insiders bought or sold shares recently?
In the 90 days to 2 Nov 2026, no Vertex Pharmaceuticals insider bought or sold shares on the open market; all 4 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Form 4, 90 days to 2 Nov 2026, newest Form 4 filing 20 Oct 2026
Buys 0Sells 0Other filings 4
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 20 Oct 2026 | Brennan Daniel J.Director | Award | 795 | 400K USD |
| 08 Sep 2026 | van Grunsven JasperEVP, CP and NPPO | Award | 8,682 | |
| 28 Aug 2026 | Ambrose KristenSVP & Chief Accounting Officer | Award | 5,000 | |
| 27 Aug 2026 | SACHS BRUCE IDirector | Gift | 6,000 |
Which funds hold Vertex Pharmaceuticals (VRTX)?
13 of the 45 institutional funds we track reported a Vertex Pharmaceuticals position for the quarter ended 30 Jun 2026 — a combined 1.5B USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| AQR Capital Management | Added | 616,170 | 305.0M USD | +260.3% |
| Marshall Wace | Added | 543,897 | 270.2M USD | +71.5% |
| Citadel Advisors | Added | 510,430 | 253.5M USD | +50.4% |
| Millennium Management | Added | 468,410 | 232.7M USD | +1,419.7% |
| Renaissance Technologies | Held (±25%) | 320,008 | 159.0M USD | −24.1% |
| Two Sigma Investments | Held (±25%) | 285,000 | 141.6M USD | −24.6% |
| Balyasny Asset Management | Added | 145,005 | 72.0M USD | +261.3% |
| Man Group | Trimmed | 139,233 | 69.2M USD | −41.2% |
| Tudor Investment Corp | New position | 30,176 | 15.0M USD | |
| Fisher Asset Management | Held (±25%) | 24,478 | 12.2M USD | −21.4% |
Showing the 10 largest of 13 reported positions. The figures above count all of them.
Have members of Congress traded Vertex Pharmaceuticals (VRTX)?
The most recent congressional trade disclosed in Vertex Pharmaceuticals is a purchase by David J. Taylor (house, OH), dated 07 Aug 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 07 Aug 2025 | David J. Taylorhouse · Republican–OH | Purchase | 1K USD–15K USD | 26 days |
| 11 Jun 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 63 days |
| 10 Jun 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 64 days |
| 12 May 2025 | Jefferson Shrevehouse · Republican–IN | Sale | 15K USD–50K USD | 41 days |
| 20 Mar 2025 | Byron Donaldshouse · Republican–FL | Sale | 1K USD–15K USD | 25 days |
| 24 Feb 2025 | Jefferson Shrevehouse · Republican–IN | Purchase | 15K USD–50K USD | 13 days |
| 11 Dec 2024 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 245 days |
| 24 Oct 2023 | Greg Stantonhouse · Democrat–AZ | Sale | 1K USD–15K USD | 16 days |
What has been filed or recorded for Vertex Pharmaceuticals (VRTX)?
The filings we hold for Vertex Pharmaceuticals, newest first: 7 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 424 shares | 206K USD notional · <0.001% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 919 shares | 466K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 46 shares | 23K USD notional · <0.001% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 622 shares | 314K USD notional · <0.001% of shares out |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 2 shares | 1K USD notional · <0.001% of shares out |
| 24 Sep 2026 | Fails to deliver | Shares failed to deliver | 24,619 shares | 12.7M USD notional · 0.010% of shares out |
| 17 Sep 2026 | Fails to deliver | Shares failed to deliver | 126 shares | 65K USD notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 4.31 USD | |
| 30 Jun 2026 | Financials | Total assets | 27.4B USD | at period end |
| 30 Jun 2026 | Financials | Total equity | 20.2B USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 4.02 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 15.32 USD | |
| 31 Dec 2025 | Financials | Revenue | 12.0B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 4.0B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 15.32 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 4.20 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 3.99 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 2.49 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −2.08 USD | |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS 4.01 USD |
What is Reddit saying about Vertex Pharmaceuticals (VRTX)?
Reddit mentioned VRTX 15 times in the 30 days to 1 November 2026, across 3 of the communities we track. All of them were scored for sentiment: 47% read bullish, 0% bearish and 53% neither. Reddit data updated 1 November 2026.
30-day window, Method
Mentions, 30 days 15Bullish 47%Bearish 0%Communities 3Against the market −7 points
How do Reddit mentions of Vertex Pharmaceuticals (VRTX) compare with its price?
Share ↗
Is the Reddit crowd more bullish on Vertex Pharmaceuticals than on the market?
VRTX reads 50% bullish, 3 points below the market (53%). Over 90 days the gap has run from -40 to +44 points.
- VRTX
- 50%
- bullish, 1 Nov
- Market
- 53%
- bullish, all Reddit, 1 Nov
- Gap
- −3 pts
- VRTX against market
Where Vertex Pharmaceuticals (VRTX) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 57% | 8 | +0.08 |
| r/stocks | 29% | 4 | +0.06 |
| r/investing | 14% | 2 | +0.10 |
Moves with Vertex Pharmaceuticals (VRTX)
Tickers whose daily Reddit volume rose and fell with Vertex Pharmaceuticals (VRTX)'s. Co-discussion, not price.
ANTHROPIC.PRV +0.65BC +0.64PERPLEXITY.PRV +0.63AMC +0.60QUBT +0.59CSCO +0.59
How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations), Method
Vertex Pharmaceuticals (VRTX): frequently asked questions
What did Vertex Pharmaceuticals shares close at?
Vertex Pharmaceuticals closed at 559.05 USD on 30 Oct 2026, up 3.51% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Vertex Pharmaceuticals’ market cap?
Vertex Pharmaceuticals is worth 141.7B USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is Vertex Pharmaceuticals’ P/E ratio?
Vertex Pharmaceuticals has a price-to-earnings ratio of 32.6, as of 30 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Vertex Pharmaceuticals’ revenue?
Vertex Pharmaceuticals reported revenue of 12.0B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Vertex Pharmaceuticals insiders bought or sold shares recently?
In the 90 days to 2 Nov 2026, no Vertex Pharmaceuticals insider bought or sold shares on the open market; all 4 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders
Which funds own Vertex Pharmaceuticals?
13 of the 45 funds we track reported a Vertex Pharmaceuticals position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Marshall Wace and Citadel Advisors. See Funds
Have members of Congress traded Vertex Pharmaceuticals?
Yes. 15 trades in Vertex Pharmaceuticals appear in the congressional disclosures we hold; the latest is a purchase by David J. Taylor (House, OH) dated 7 Aug 2025, filed 2 Sep 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Vertex Pharmaceuticals last report earnings?
Vertex Pharmaceuticals last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of 4.31 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Vertex Pharmaceuticals?
Vertex Pharmaceuticals was mentioned 8 times in the last 7 days across the finance subreddits we track, and 15 times over the trailing 30 days. Of the 15 mentions scored for sentiment, 47% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings